Advanced search
Publication Cover
Current Medical Research and Opinion Volume 38, 2022 - Issue 8
Submit an article Journal homepage
1,377
Views
13
CrossRef citations to date
0
Altmetric
Revolutionary Victories in Cancer Care

Non-small cell lung cancer with EGFR exon 20 insertion mutation: a systematic literature review and meta-analysis of patient outcomes

Christina Soeun Kwona RWA Value and Access, Cytel, Inc., Waltham, MA, USA
,
Huamao M. Linb Takeda Oncology, Development Center Americas, Inc., Lexington, MA, USAORCID Iconhttps://orcid.org/0000-0002-8399-8966
ORCID Icon,
Victoria Crosslandb Takeda Oncology, Development Center Americas, Inc., Lexington, MA, USA
,
Eric N. Churchillc Global Medical Lead, Takeda Pharmaceuticals USA, Inc., Lexington, MA, USA
,
Eileen Curranb Takeda Oncology, Development Center Americas, Inc., Lexington, MA, USA
,
Anna Forsythea RWA Value and Access, Cytel, Inc., Waltham, MA, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-6017-1926
ORCID Icon,
Dimitrios Tomarasd Health Economics and Real World Evidence, Purple Squirrel Economics, Montreal, QC, Canada, a wholly owned subsidiary of Cytel, Inc;
&
Sai-Hong Ignatius Oue Chao Family Comprehensive Cancer Center, University of California Irvine School of Medicine, Orange, CA, USA
 show all
Pages 1341-1350 | Received 21 Mar 2022, Accepted 24 May 2022, Published online: 20 Jun 2022

Citations (13)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Tae Min Kim, Nicolas Girard, Natasha B Leighl, Joshua Sabari, Nora Rahhali, Claudio A Schioppa, Joris Diels, Jan Sermon, Conor Chandler, Venediktos Kapetanakis, Ruhee Jain, Tracy Li & Suzy Van Sanden. (2024) Matching-Adjusted Indirect Comparison of Amivantamab vs Mobocertinib in Platinum-Pretreated EGFR Exon 20 Insertion-Mutated Non-Small-Cell Lung Cancer. Future Oncology 20:8, pages 447-458.
Read now

Articles from other publishers (12)

Zishun Guo, Xin Zhang, Dingtao Yang, Zhuozheng Hu, Jiajun Wu, Weijun Zhou, Shuoming Wu & Wenxiong Zhang. (2024) Gefitinib metabolism-related lncRNAs for the prediction of prognosis, tumor microenvironment and drug sensitivity in lung adenocarcinoma. Scientific Reports 14:1.
Crossref
Michael J. Hanley, D. Ross Camidge, Robert J. Fram & Neeraj Gupta. (2024) Mobocertinib: Mechanism of action, clinical, and translational science. Clinical and Translational Science 17:3.
Crossref
Jingwen Liu, Yan Xiang, Tingwen Fang, Lulin Zeng, Ao Sun, Yixiang Lin & Kaihua Lu. (2024) Advances in the Diagnosis and Treatment of Advanced Non–Small-Cell Lung Cancer With EGFR Exon 20 Insertion Mutation. Clinical Lung Cancer 25:2, pages 100-108.
Crossref
Petros Christopoulos, Nicolas Girard, Claudia Proto, Marta Soares, Pilar Garrido Lopez, Anthonie J. van der Wekken, Sanjay Popat, Joris Diels, Claudio A. Schioppa, Jan Sermon, Nora Rahhali, Corinna Pick-Lauer, Agnieszka Adamczyk, James Penton & Marie Wislez. (2023) Amivantamab Compared with Real-World Physician’s Choice after Platinum-Based Therapy from a Pan-European Chart Review of Patients with Lung Cancer and Activating EGFR Exon 20 Insertion Mutations. Cancers 15:22, pages 5326.
Crossref
Binyang Pan, Jiaqi Liang, Haochun Shi, Kungeng Rao, Weigang Guo & Cheng Zhan. (2023) Epidemiological characteristics and therapeutic advances of EGFR exon 20 insertion mutations in non‐small cell lung cancer . Thoracic Cancer 14:33, pages 3247-3258.
Crossref
Xin Xie, Tingting Yu, Xiang Li, Nan Zhang, Leonard J. Foster, Cheng Peng, Wei Huang & Gu He. (2023) Recent advances in targeting the “undruggable” proteins: from drug discovery to clinical trials. Signal Transduction and Targeted Therapy 8:1.
Crossref
Sai-Hong Ignatius Ou, Jin-Liern Hong, Petros Christopoulos, Huamao M. Lin, Sylvie Vincent, Eric N. Churchill, Junpei Soeda, Daniel Kazdal, Albrecht Stenzinger & Michael Thomas. (2023) Distribution and Detectability of EGFR Exon 20 Insertion Variants in NSCLC. Journal of Thoracic Oncology 18:6, pages 744-754.
Crossref
Sai-Hong I. Ou, Huamao M. Lin, Jin-Liern Hong, Yu Yin, Shu Jin, Jianchang Lin, Minal Mehta, Pingkuan Zhang, Danny Nguyen & Joel W. Neal. (2023) Comparative effectiveness of mobocertinib and standard of care in patients with NSCLC with EGFR exon 20 insertion mutations: An indirect comparison. Lung Cancer 179, pages 107186.
Crossref
Ping-Chih Hsu, Suey-Haur Lee, Li-Chung Chiu, Chung-Shu Lee, Chiao-En Wu, Scott Chih-Hsi Kuo, Jia-Shiuan Ju, Allen Chung-Cheng Huang, Shih-Hong Li, Ho-Wen Ko, Cheng-Ta Yang & Chin-Chou Wang. (2023) Afatinib in Untreated Stage IIIB/IV Lung Adenocarcinoma with Major Uncommon Epidermal Growth Factor Receptor (EGFR) Mutations (G719X/L861Q/S768I): A Multicenter Observational Study in Taiwan. Targeted Oncology 18:2, pages 195-207.
Crossref
Chao-Wen Lu, Mong-Wei Lin, Xu-Heng Chiang, Hsao-Hsun Hsu, Min-Shu Hsieh & Jin-Shing Chen. (2023) Clinicopathological Features and Significance of Epidermal Growth Factor Receptor Mutation in Surgically Resected Early-Stage Lung Adenocarcinoma. Diagnostics 13:3, pages 390.
Crossref
Harsh Sahu. (2023) Amivantamab in non-small-cell lung cancer. Cancer Research, Statistics, and Treatment 6:3, pages 486-487.
Crossref
Zixi Wang, Yurou Xing, Bingjie Li, Xiaoyu Li, Bin Liu & Yongsheng Wang. (2022) Molecular pathways, resistance mechanisms and targeted interventions in non-small-cell lung cancer. Molecular Biomedicine 3:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.